nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—LTK—systemic lupus erythematosus	0.411	0.92	CbGaD
Erlotinib—ALB—systemic lupus erythematosus	0.0355	0.0796	CbGaD
Erlotinib—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.0287	0.0901	CbGbCtD
Erlotinib—ABCG2—Leflunomide—systemic lupus erythematosus	0.0255	0.0802	CbGbCtD
Erlotinib—CYP1B1—Dexamethasone—systemic lupus erythematosus	0.0166	0.052	CbGbCtD
Erlotinib—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0158	0.0496	CbGbCtD
Erlotinib—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0127	0.0398	CbGbCtD
Erlotinib—ABCG2—Cyclosporine—systemic lupus erythematosus	0.012	0.0376	CbGbCtD
Erlotinib—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0109	0.0342	CbGbCtD
Erlotinib—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0105	0.0331	CbGbCtD
Erlotinib—CYP3A5—Dapsone—systemic lupus erythematosus	0.0101	0.0317	CbGbCtD
Erlotinib—STK10—renal vein—systemic lupus erythematosus	0.00971	0.17	CbGeAlD
Erlotinib—CYP2C8—Dapsone—systemic lupus erythematosus	0.0097	0.0304	CbGbCtD
Erlotinib—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.00874	0.0275	CbGbCtD
Erlotinib—ALB—Prednisone—systemic lupus erythematosus	0.0087	0.0273	CbGbCtD
Erlotinib—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.00841	0.0264	CbGbCtD
Erlotinib—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00788	0.0247	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00751	0.0236	CbGbCtD
Erlotinib—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.00727	0.0228	CbGbCtD
Erlotinib—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.00702	0.022	CbGbCtD
Erlotinib—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00675	0.0212	CbGbCtD
Erlotinib—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.00663	0.0208	CbGbCtD
Erlotinib—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00637	0.02	CbGbCtD
Erlotinib—ABCG2—Methotrexate—systemic lupus erythematosus	0.00633	0.0199	CbGbCtD
Erlotinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00569	0.0179	CbGbCtD
Erlotinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00488	0.0153	CbGbCtD
Erlotinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.00482	0.0151	CbGbCtD
Erlotinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00457	0.0143	CbGbCtD
Erlotinib—ABCB1—Prednisone—systemic lupus erythematosus	0.00455	0.0143	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0045	0.0141	CbGbCtD
Erlotinib—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.00436	0.0137	CbGbCtD
Erlotinib—ALB—Methotrexate—systemic lupus erythematosus	0.00436	0.0137	CbGbCtD
Erlotinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00431	0.0135	CbGbCtD
Erlotinib—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0042	0.0132	CbGbCtD
Erlotinib—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00406	0.0128	CbGbCtD
Erlotinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.00393	0.0123	CbGbCtD
Erlotinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00341	0.0107	CbGbCtD
Erlotinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00341	0.0107	CbGbCtD
Erlotinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00293	0.00919	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00289	0.00906	CbGbCtD
Erlotinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00284	0.00892	CbGbCtD
Erlotinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00274	0.00859	CbGbCtD
Erlotinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00273	0.00856	CbGbCtD
Erlotinib—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00268	0.0084	CbGbCtD
Erlotinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00258	0.00811	CbGbCtD
Erlotinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00228	0.00717	CbGbCtD
Erlotinib—UGT1A1—urine—systemic lupus erythematosus	0.00173	0.0302	CbGeAlD
Erlotinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0017	0.00534	CbGbCtD
Erlotinib—FLT3—blood plasma—systemic lupus erythematosus	0.00143	0.025	CbGeAlD
Erlotinib—Vandetanib—LYN—systemic lupus erythematosus	0.00142	0.335	CrCbGaD
Erlotinib—Vandetanib—LTK—systemic lupus erythematosus	0.00134	0.317	CrCbGaD
Erlotinib—JAK3—connective tissue—systemic lupus erythematosus	0.000964	0.0169	CbGeAlD
Erlotinib—STK10—blood plasma—systemic lupus erythematosus	0.000955	0.0167	CbGeAlD
Erlotinib—UGT1A1—blood plasma—systemic lupus erythematosus	0.000902	0.0158	CbGeAlD
Erlotinib—Vandetanib—BLK—systemic lupus erythematosus	0.000813	0.192	CrCbGaD
Erlotinib—CYP1A2—urine—systemic lupus erythematosus	0.000765	0.0134	CbGeAlD
Erlotinib—FLT3—connective tissue—systemic lupus erythematosus	0.000761	0.0133	CbGeAlD
Erlotinib—LTK—lung—systemic lupus erythematosus	0.000727	0.0127	CbGeAlD
Erlotinib—AURKC—tendon—systemic lupus erythematosus	0.000716	0.0125	CbGeAlD
Erlotinib—JAK3—lymphoid tissue—systemic lupus erythematosus	0.000705	0.0123	CbGeAlD
Erlotinib—PIP4K2C—nephron tubule—systemic lupus erythematosus	0.000666	0.0116	CbGeAlD
Erlotinib—TNK1—tendon—systemic lupus erythematosus	0.000608	0.0106	CbGeAlD
Erlotinib—JAK3—lung—systemic lupus erythematosus	0.000582	0.0102	CbGeAlD
Erlotinib—AURKC—nervous system—systemic lupus erythematosus	0.000582	0.0102	CbGeAlD
Erlotinib—PIP4K2C—cortex of kidney—systemic lupus erythematosus	0.00057	0.00996	CbGeAlD
Erlotinib—SLK—nephron tubule—systemic lupus erythematosus	0.000566	0.00991	CbGeAlD
Erlotinib—AURKC—central nervous system—systemic lupus erythematosus	0.00056	0.00979	CbGeAlD
Erlotinib—FLT3—lymphoid tissue—systemic lupus erythematosus	0.000556	0.00973	CbGeAlD
Erlotinib—CYP3A4—urine—systemic lupus erythematosus	0.000554	0.00969	CbGeAlD
Erlotinib—CYP2D6—urine—systemic lupus erythematosus	0.000545	0.00953	CbGeAlD
Erlotinib—ULK3—cortex of kidney—systemic lupus erythematosus	0.000544	0.00951	CbGeAlD
Erlotinib—JAK3—nervous system—systemic lupus erythematosus	0.000539	0.00942	CbGeAlD
Erlotinib—EPHA6—nervous system—systemic lupus erythematosus	0.000539	0.00942	CbGeAlD
Erlotinib—TNK1—lung—systemic lupus erythematosus	0.000534	0.00934	CbGeAlD
Erlotinib—MAP3K19—lung—systemic lupus erythematosus	0.000529	0.00925	CbGeAlD
Erlotinib—JAK3—central nervous system—systemic lupus erythematosus	0.000519	0.00907	CbGeAlD
Erlotinib—EPHA6—central nervous system—systemic lupus erythematosus	0.000519	0.00907	CbGeAlD
Erlotinib—MKNK1—cortex of kidney—systemic lupus erythematosus	0.000512	0.00895	CbGeAlD
Erlotinib—FLT3—bone marrow—systemic lupus erythematosus	0.000506	0.00886	CbGeAlD
Erlotinib—ABL2—tendon—systemic lupus erythematosus	0.000499	0.00873	CbGeAlD
Erlotinib—MAP3K19—nervous system—systemic lupus erythematosus	0.000489	0.00856	CbGeAlD
Erlotinib—SLK—cortex of kidney—systemic lupus erythematosus	0.000485	0.00848	CbGeAlD
Erlotinib—PIP4K2C—tendon—systemic lupus erythematosus	0.000472	0.00826	CbGeAlD
Erlotinib—MAP3K19—central nervous system—systemic lupus erythematosus	0.000471	0.00824	CbGeAlD
Erlotinib—FLT3—lung—systemic lupus erythematosus	0.000459	0.00803	CbGeAlD
Erlotinib—PIP4K2C—bone marrow—systemic lupus erythematosus	0.000457	0.008	CbGeAlD
Erlotinib—MKNK1—lymphoid tissue—systemic lupus erythematosus	0.000451	0.0079	CbGeAlD
Erlotinib—ULK3—tendon—systemic lupus erythematosus	0.000451	0.00789	CbGeAlD
Erlotinib—ABL2—lung—systemic lupus erythematosus	0.000438	0.00766	CbGeAlD
Erlotinib—ULK3—bone marrow—systemic lupus erythematosus	0.000437	0.00764	CbGeAlD
Erlotinib—STK10—kidney—systemic lupus erythematosus	0.000433	0.00757	CbGeAlD
Erlotinib—Vandetanib—VEGFA—systemic lupus erythematosus	0.000432	0.102	CrCbGaD
Erlotinib—EGFR—lung—systemic lupus erythematosus	0.000427	0.00748	CbGeAlD
Erlotinib—CYP2C8—blood plasma—systemic lupus erythematosus	0.000427	0.00746	CbGeAlD
Erlotinib—PIP4K2C—lung—systemic lupus erythematosus	0.000414	0.00725	CbGeAlD
Erlotinib—MKNK1—bone marrow—systemic lupus erythematosus	0.000411	0.00719	CbGeAlD
Erlotinib—UGT1A1—kidney—systemic lupus erythematosus	0.000409	0.00715	CbGeAlD
Erlotinib—SLK—tendon—systemic lupus erythematosus	0.000402	0.00703	CbGeAlD
Erlotinib—CYP1A2—blood plasma—systemic lupus erythematosus	0.000399	0.00698	CbGeAlD
Erlotinib—ULK3—lung—systemic lupus erythematosus	0.000396	0.00692	CbGeAlD
Erlotinib—SLK—bone marrow—systemic lupus erythematosus	0.000389	0.00681	CbGeAlD
Erlotinib—CYP3A5—blood plasma—systemic lupus erythematosus	0.000385	0.00674	CbGeAlD
Erlotinib—PIP4K2C—nervous system—systemic lupus erythematosus	0.000384	0.00671	CbGeAlD
Erlotinib—MAP2K5—cortex of kidney—systemic lupus erythematosus	0.000376	0.00659	CbGeAlD
Erlotinib—MKNK1—lung—systemic lupus erythematosus	0.000372	0.00651	CbGeAlD
Erlotinib—STK10—lymphoid tissue—systemic lupus erythematosus	0.000372	0.0065	CbGeAlD
Erlotinib—PIP4K2C—central nervous system—systemic lupus erythematosus	0.000369	0.00646	CbGeAlD
Erlotinib—ULK3—nervous system—systemic lupus erythematosus	0.000366	0.00641	CbGeAlD
Erlotinib—ULK3—central nervous system—systemic lupus erythematosus	0.000353	0.00617	CbGeAlD
Erlotinib—SLK—lung—systemic lupus erythematosus	0.000353	0.00617	CbGeAlD
Erlotinib—ABL1—connective tissue—systemic lupus erythematosus	0.00035	0.00613	CbGeAlD
Erlotinib—STK10—tendon—systemic lupus erythematosus	0.000349	0.00611	CbGeAlD
Erlotinib—MKNK1—nervous system—systemic lupus erythematosus	0.000345	0.00603	CbGeAlD
Erlotinib—ABL1—nephron tubule—systemic lupus erythematosus	0.000339	0.00594	CbGeAlD
Erlotinib—STK10—bone marrow—systemic lupus erythematosus	0.000339	0.00592	CbGeAlD
Erlotinib—MKNK1—central nervous system—systemic lupus erythematosus	0.000332	0.00581	CbGeAlD
Erlotinib—ABL1—skin of body—systemic lupus erythematosus	0.000316	0.00553	CbGeAlD
Erlotinib—MAP2K5—tendon—systemic lupus erythematosus	0.000312	0.00546	CbGeAlD
Erlotinib—STK10—lung—systemic lupus erythematosus	0.000307	0.00536	CbGeAlD
Erlotinib—SLCO2B1—kidney—systemic lupus erythematosus	0.000301	0.00526	CbGeAlD
Erlotinib—ABL1—kidney—systemic lupus erythematosus	0.000298	0.00522	CbGeAlD
Erlotinib—CYP1B1—connective tissue—systemic lupus erythematosus	0.000297	0.00519	CbGeAlD
Erlotinib—ABL1—cortex of kidney—systemic lupus erythematosus	0.00029	0.00508	CbGeAlD
Erlotinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.000289	0.00506	CbGeAlD
Erlotinib—CYP1B1—nephron tubule—systemic lupus erythematosus	0.000287	0.00503	CbGeAlD
Erlotinib—CYP2D6—blood plasma—systemic lupus erythematosus	0.000284	0.00498	CbGeAlD
Erlotinib—STK10—nervous system—systemic lupus erythematosus	0.000284	0.00497	CbGeAlD
Erlotinib—MAP2K5—lung—systemic lupus erythematosus	0.000274	0.00479	CbGeAlD
Erlotinib—STK10—central nervous system—systemic lupus erythematosus	0.000273	0.00478	CbGeAlD
Erlotinib—CYP1B1—skin of body—systemic lupus erythematosus	0.000268	0.00469	CbGeAlD
Erlotinib—ABL1—lymphoid tissue—systemic lupus erythematosus	0.000256	0.00448	CbGeAlD
Erlotinib—MAP2K5—nervous system—systemic lupus erythematosus	0.000254	0.00444	CbGeAlD
Erlotinib—CYP1B1—kidney—systemic lupus erythematosus	0.000253	0.00442	CbGeAlD
Erlotinib—CYP1B1—cortex of kidney—systemic lupus erythematosus	0.000246	0.0043	CbGeAlD
Erlotinib—ORM1—bone marrow—systemic lupus erythematosus	0.000245	0.00429	CbGeAlD
Erlotinib—MAP2K5—central nervous system—systemic lupus erythematosus	0.000244	0.00427	CbGeAlD
Erlotinib—SLCO2B1—tendon—systemic lupus erythematosus	0.000243	0.00425	CbGeAlD
Erlotinib—ABL1—tendon—systemic lupus erythematosus	0.000241	0.00421	CbGeAlD
Erlotinib—ABL1—bone marrow—systemic lupus erythematosus	0.000233	0.00408	CbGeAlD
Erlotinib—ORM1—lung—systemic lupus erythematosus	0.000222	0.00389	CbGeAlD
Erlotinib—CYP1B1—lymphoid tissue—systemic lupus erythematosus	0.000217	0.00379	CbGeAlD
Erlotinib—ABCG2—nephron tubule—systemic lupus erythematosus	0.000214	0.00374	CbGeAlD
Erlotinib—SLCO2B1—lung—systemic lupus erythematosus	0.000213	0.00373	CbGeAlD
Erlotinib—ABL1—lung—systemic lupus erythematosus	0.000211	0.0037	CbGeAlD
Erlotinib—ORM1—nervous system—systemic lupus erythematosus	0.000206	0.0036	CbGeAlD
Erlotinib—ABCB1—blood plasma—systemic lupus erythematosus	0.000205	0.00358	CbGeAlD
Erlotinib—CYP1B1—tendon—systemic lupus erythematosus	0.000204	0.00357	CbGeAlD
Erlotinib—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000199	0.00347	CbGeAlD
Erlotinib—ORM1—central nervous system—systemic lupus erythematosus	0.000198	0.00347	CbGeAlD
Erlotinib—SLCO2B1—nervous system—systemic lupus erythematosus	0.000197	0.00345	CbGeAlD
Erlotinib—ABL1—nervous system—systemic lupus erythematosus	0.000196	0.00342	CbGeAlD
Erlotinib—CYP2C8—kidney—systemic lupus erythematosus	0.000193	0.00338	CbGeAlD
Erlotinib—SLCO2B1—central nervous system—systemic lupus erythematosus	0.00019	0.00332	CbGeAlD
Erlotinib—CYP1A1—skin of body—systemic lupus erythematosus	0.000189	0.00331	CbGeAlD
Erlotinib—ABL1—central nervous system—systemic lupus erythematosus	0.000188	0.0033	CbGeAlD
Erlotinib—CYP1B1—lung—systemic lupus erythematosus	0.000179	0.00313	CbGeAlD
Erlotinib—CYP1A1—kidney—systemic lupus erythematosus	0.000179	0.00312	CbGeAlD
Erlotinib—CYP3A5—kidney—systemic lupus erythematosus	0.000175	0.00305	CbGeAlD
Erlotinib—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.00017	0.00297	CbGeAlD
Erlotinib—CYP1B1—nervous system—systemic lupus erythematosus	0.000166	0.0029	CbGeAlD
Erlotinib—CYP1B1—central nervous system—systemic lupus erythematosus	0.00016	0.00279	CbGeAlD
Erlotinib—ABCG2—bone marrow—systemic lupus erythematosus	0.000147	0.00257	CbGeAlD
Erlotinib—ABCG2—lung—systemic lupus erythematosus	0.000133	0.00233	CbGeAlD
Erlotinib—CYP3A4—kidney—systemic lupus erythematosus	0.000131	0.00229	CbGeAlD
Erlotinib—CYP2D6—kidney—systemic lupus erythematosus	0.000129	0.00225	CbGeAlD
Erlotinib—CYP1A2—lung—systemic lupus erythematosus	0.000128	0.00224	CbGeAlD
Erlotinib—CYP1A1—lung—systemic lupus erythematosus	0.000126	0.00221	CbGeAlD
Erlotinib—CYP3A5—lung—systemic lupus erythematosus	0.000124	0.00216	CbGeAlD
Erlotinib—CYP1A1—nervous system—systemic lupus erythematosus	0.000117	0.00205	CbGeAlD
Erlotinib—Vandetanib—ALB—systemic lupus erythematosus	0.000116	0.0275	CrCbGaD
Erlotinib—CYP1A1—central nervous system—systemic lupus erythematosus	0.000113	0.00197	CbGeAlD
Erlotinib—Gefitinib—ALB—systemic lupus erythematosus	0.00011	0.0261	CrCbGaD
Erlotinib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000106	0.00185	CbGeAlD
Erlotinib—ABCB1—kidney—systemic lupus erythematosus	9.27e-05	0.00162	CbGeAlD
Erlotinib—ABCB1—cortex of kidney—systemic lupus erythematosus	9.03e-05	0.00158	CbGeAlD
Erlotinib—CYP3A4—nervous system—systemic lupus erythematosus	8.6e-05	0.0015	CbGeAlD
Erlotinib—CYP2D6—nervous system—systemic lupus erythematosus	8.46e-05	0.00148	CbGeAlD
Erlotinib—CYP3A4—central nervous system—systemic lupus erythematosus	8.28e-05	0.00145	CbGeAlD
Erlotinib—CYP2D6—central nervous system—systemic lupus erythematosus	8.14e-05	0.00142	CbGeAlD
Erlotinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	7.96e-05	0.00139	CbGeAlD
Erlotinib—ABCB1—bone marrow—systemic lupus erythematosus	7.25e-05	0.00127	CbGeAlD
Erlotinib—Depression—Methotrexate—systemic lupus erythematosus	6.83e-05	0.000633	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	6.83e-05	0.000632	CcSEcCtD
Erlotinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	6.83e-05	0.000632	CcSEcCtD
Erlotinib—Fatigue—Cyclosporine—systemic lupus erythematosus	6.82e-05	0.000632	CcSEcCtD
Erlotinib—Headache—Azathioprine—systemic lupus erythematosus	6.8e-05	0.00063	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Methotrexate—systemic lupus erythematosus	6.8e-05	0.000629	CcSEcCtD
Erlotinib—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	6.79e-05	0.000629	CcSEcCtD
Erlotinib—Dizziness—Leflunomide—systemic lupus erythematosus	6.78e-05	0.000628	CcSEcCtD
Erlotinib—Constipation—Cyclosporine—systemic lupus erythematosus	6.76e-05	0.000626	CcSEcCtD
Erlotinib—Pain—Cyclosporine—systemic lupus erythematosus	6.76e-05	0.000626	CcSEcCtD
Erlotinib—Renal failure—Methotrexate—systemic lupus erythematosus	6.74e-05	0.000624	CcSEcCtD
Erlotinib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	6.71e-05	0.000621	CcSEcCtD
Erlotinib—Anorexia—Hydrocortisone—systemic lupus erythematosus	6.7e-05	0.000621	CcSEcCtD
Erlotinib—Stomatitis—Methotrexate—systemic lupus erythematosus	6.68e-05	0.000619	CcSEcCtD
Erlotinib—Conjunctivitis—Methotrexate—systemic lupus erythematosus	6.66e-05	0.000617	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	6.66e-05	0.000617	CcSEcCtD
Erlotinib—Oedema—Triamcinolone—systemic lupus erythematosus	6.62e-05	0.000613	CcSEcCtD
Erlotinib—Syncope—Dexamethasone—systemic lupus erythematosus	6.6e-05	0.000611	CcSEcCtD
Erlotinib—Syncope—Betamethasone—systemic lupus erythematosus	6.6e-05	0.000611	CcSEcCtD
Erlotinib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	6.6e-05	0.000611	CcSEcCtD
Erlotinib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	6.6e-05	0.000611	CcSEcCtD
Erlotinib—Arrhythmia—Prednisone—systemic lupus erythematosus	6.58e-05	0.000609	CcSEcCtD
Erlotinib—Infection—Triamcinolone—systemic lupus erythematosus	6.58e-05	0.000609	CcSEcCtD
Erlotinib—ABCB1—lung—systemic lupus erythematosus	6.57e-05	0.00115	CbGeAlD
Erlotinib—Infection—Methylprednisolone—systemic lupus erythematosus	6.56e-05	0.000608	CcSEcCtD
Erlotinib—Vomiting—Leflunomide—systemic lupus erythematosus	6.52e-05	0.000603	CcSEcCtD
Erlotinib—Shock—Triamcinolone—systemic lupus erythematosus	6.51e-05	0.000603	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—systemic lupus erythematosus	6.51e-05	0.000603	CcSEcCtD
Erlotinib—Alopecia—Prednisone—systemic lupus erythematosus	6.51e-05	0.000602	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—systemic lupus erythematosus	6.5e-05	0.000602	CcSEcCtD
Erlotinib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	6.48e-05	0.0006	CcSEcCtD
Erlotinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	6.48e-05	0.0006	CcSEcCtD
Erlotinib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	6.47e-05	0.000599	CcSEcCtD
Erlotinib—Loss of consciousness—Betamethasone—systemic lupus erythematosus	6.47e-05	0.000599	CcSEcCtD
Erlotinib—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	6.47e-05	0.000599	CcSEcCtD
Erlotinib—Epistaxis—Methotrexate—systemic lupus erythematosus	6.46e-05	0.000599	CcSEcCtD
Erlotinib—Rash—Leflunomide—systemic lupus erythematosus	6.46e-05	0.000598	CcSEcCtD
Erlotinib—Dermatitis—Leflunomide—systemic lupus erythematosus	6.46e-05	0.000598	CcSEcCtD
Erlotinib—Mental disorder—Prednisone—systemic lupus erythematosus	6.45e-05	0.000597	CcSEcCtD
Erlotinib—Nausea—Azathioprine—systemic lupus erythematosus	6.45e-05	0.000597	CcSEcCtD
Erlotinib—Headache—Leflunomide—systemic lupus erythematosus	6.42e-05	0.000595	CcSEcCtD
Erlotinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	6.42e-05	0.000594	CcSEcCtD
Erlotinib—Malnutrition—Prednisone—systemic lupus erythematosus	6.41e-05	0.000593	CcSEcCtD
Erlotinib—Erythema—Prednisone—systemic lupus erythematosus	6.41e-05	0.000593	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	6.4e-05	0.000593	CcSEcCtD
Erlotinib—Insomnia—Hydrocortisone—systemic lupus erythematosus	6.36e-05	0.000589	CcSEcCtD
Erlotinib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.31e-05	0.000584	CcSEcCtD
Erlotinib—Myalgia—Betamethasone—systemic lupus erythematosus	6.27e-05	0.00058	CcSEcCtD
Erlotinib—Myalgia—Dexamethasone—systemic lupus erythematosus	6.27e-05	0.00058	CcSEcCtD
Erlotinib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	6.25e-05	0.000579	CcSEcCtD
Erlotinib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	6.25e-05	0.000579	CcSEcCtD
Erlotinib—Anxiety—Dexamethasone—systemic lupus erythematosus	6.24e-05	0.000578	CcSEcCtD
Erlotinib—Anxiety—Betamethasone—systemic lupus erythematosus	6.24e-05	0.000578	CcSEcCtD
Erlotinib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	6.19e-05	0.000573	CcSEcCtD
Erlotinib—Haemoglobin—Methotrexate—systemic lupus erythematosus	6.18e-05	0.000573	CcSEcCtD
Erlotinib—Pain—Prednisolone—systemic lupus erythematosus	6.16e-05	0.00057	CcSEcCtD
Erlotinib—Haemorrhage—Methotrexate—systemic lupus erythematosus	6.15e-05	0.00057	CcSEcCtD
Erlotinib—Hepatitis—Methotrexate—systemic lupus erythematosus	6.15e-05	0.00057	CcSEcCtD
Erlotinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	6.11e-05	0.000566	CcSEcCtD
Erlotinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	6.1e-05	0.000565	CcSEcCtD
Erlotinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.1e-05	0.000565	CcSEcCtD
Erlotinib—Nausea—Leflunomide—systemic lupus erythematosus	6.09e-05	0.000564	CcSEcCtD
Erlotinib—ABCB1—nervous system—systemic lupus erythematosus	6.08e-05	0.00106	CbGeAlD
Erlotinib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	6.08e-05	0.000563	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	6.07e-05	0.000562	CcSEcCtD
Erlotinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	6.06e-05	0.000561	CcSEcCtD
Erlotinib—Urethral disorder—Methotrexate—systemic lupus erythematosus	6.03e-05	0.000559	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	6.03e-05	0.000558	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	6.02e-05	0.000557	CcSEcCtD
Erlotinib—Pain—Hydrocortisone—systemic lupus erythematosus	6.01e-05	0.000557	CcSEcCtD
Erlotinib—Oedema—Dexamethasone—systemic lupus erythematosus	6.01e-05	0.000556	CcSEcCtD
Erlotinib—Oedema—Betamethasone—systemic lupus erythematosus	6.01e-05	0.000556	CcSEcCtD
Erlotinib—Insomnia—Triamcinolone—systemic lupus erythematosus	5.99e-05	0.000554	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—systemic lupus erythematosus	5.97e-05	0.000553	CcSEcCtD
Erlotinib—Infection—Dexamethasone—systemic lupus erythematosus	5.97e-05	0.000553	CcSEcCtD
Erlotinib—Infection—Betamethasone—systemic lupus erythematosus	5.97e-05	0.000553	CcSEcCtD
Erlotinib—Shock—Betamethasone—systemic lupus erythematosus	5.91e-05	0.000547	CcSEcCtD
Erlotinib—Shock—Dexamethasone—systemic lupus erythematosus	5.91e-05	0.000547	CcSEcCtD
Erlotinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	5.9e-05	0.000546	CcSEcCtD
Erlotinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	5.89e-05	0.000545	CcSEcCtD
Erlotinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	5.89e-05	0.000545	CcSEcCtD
Erlotinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	5.88e-05	0.000545	CcSEcCtD
Erlotinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	5.88e-05	0.000545	CcSEcCtD
Erlotinib—ABCB1—central nervous system—systemic lupus erythematosus	5.86e-05	0.00102	CbGeAlD
Erlotinib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	5.83e-05	0.00054	CcSEcCtD
Erlotinib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	5.82e-05	0.000539	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	5.81e-05	0.000538	CcSEcCtD
Erlotinib—Eye disorder—Methotrexate—systemic lupus erythematosus	5.75e-05	0.000532	CcSEcCtD
Erlotinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.75e-05	0.000532	CcSEcCtD
Erlotinib—Syncope—Prednisone—systemic lupus erythematosus	5.75e-05	0.000532	CcSEcCtD
Erlotinib—Anorexia—Dexamethasone—systemic lupus erythematosus	5.73e-05	0.00053	CcSEcCtD
Erlotinib—Anorexia—Betamethasone—systemic lupus erythematosus	5.73e-05	0.00053	CcSEcCtD
Erlotinib—Fatigue—Triamcinolone—systemic lupus erythematosus	5.71e-05	0.000528	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	5.69e-05	0.000527	CcSEcCtD
Erlotinib—Asthenia—Cyclosporine—systemic lupus erythematosus	5.68e-05	0.000526	CcSEcCtD
Erlotinib—Pain—Triamcinolone—systemic lupus erythematosus	5.66e-05	0.000524	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisone—systemic lupus erythematosus	5.63e-05	0.000522	CcSEcCtD
Erlotinib—Pruritus—Cyclosporine—systemic lupus erythematosus	5.6e-05	0.000518	CcSEcCtD
Erlotinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.56e-05	0.000515	CcSEcCtD
Erlotinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.56e-05	0.000515	CcSEcCtD
Erlotinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	5.55e-05	0.000513	CcSEcCtD
Erlotinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.54e-05	0.000513	CcSEcCtD
Erlotinib—Chills—Methotrexate—systemic lupus erythematosus	5.52e-05	0.000511	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	5.47e-05	0.000507	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	5.47e-05	0.000507	CcSEcCtD
Erlotinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.46e-05	0.000506	CcSEcCtD
Erlotinib—Arthralgia—Prednisone—systemic lupus erythematosus	5.46e-05	0.000505	CcSEcCtD
Erlotinib—Myalgia—Prednisone—systemic lupus erythematosus	5.46e-05	0.000505	CcSEcCtD
Erlotinib—Anxiety—Prednisone—systemic lupus erythematosus	5.44e-05	0.000504	CcSEcCtD
Erlotinib—Alopecia—Methotrexate—systemic lupus erythematosus	5.44e-05	0.000503	CcSEcCtD
Erlotinib—Insomnia—Dexamethasone—systemic lupus erythematosus	5.43e-05	0.000503	CcSEcCtD
Erlotinib—Insomnia—Betamethasone—systemic lupus erythematosus	5.43e-05	0.000503	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	5.42e-05	0.000502	CcSEcCtD
Erlotinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.41e-05	0.000501	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.4e-05	0.0005	CcSEcCtD
Erlotinib—Mental disorder—Methotrexate—systemic lupus erythematosus	5.39e-05	0.000499	CcSEcCtD
Erlotinib—Erythema—Methotrexate—systemic lupus erythematosus	5.36e-05	0.000496	CcSEcCtD
Erlotinib—Malnutrition—Methotrexate—systemic lupus erythematosus	5.36e-05	0.000496	CcSEcCtD
Erlotinib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	5.29e-05	0.00049	CcSEcCtD
Erlotinib—Dyspepsia—Betamethasone—systemic lupus erythematosus	5.29e-05	0.00049	CcSEcCtD
Erlotinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.28e-05	0.000489	CcSEcCtD
Erlotinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.23e-05	0.000485	CcSEcCtD
Erlotinib—Dizziness—Cyclosporine—systemic lupus erythematosus	5.23e-05	0.000484	CcSEcCtD
Erlotinib—Oedema—Prednisone—systemic lupus erythematosus	5.23e-05	0.000484	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.22e-05	0.000483	CcSEcCtD
Erlotinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.22e-05	0.000483	CcSEcCtD
Erlotinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.22e-05	0.000483	CcSEcCtD
Erlotinib—Infection—Prednisone—systemic lupus erythematosus	5.2e-05	0.000481	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	5.19e-05	0.00048	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	5.19e-05	0.00048	CcSEcCtD
Erlotinib—Back pain—Methotrexate—systemic lupus erythematosus	5.18e-05	0.00048	CcSEcCtD
Erlotinib—Fatigue—Dexamethasone—systemic lupus erythematosus	5.18e-05	0.00048	CcSEcCtD
Erlotinib—Fatigue—Betamethasone—systemic lupus erythematosus	5.18e-05	0.00048	CcSEcCtD
Erlotinib—Shock—Prednisone—systemic lupus erythematosus	5.15e-05	0.000477	CcSEcCtD
Erlotinib—Pain—Betamethasone—systemic lupus erythematosus	5.14e-05	0.000476	CcSEcCtD
Erlotinib—Pain—Dexamethasone—systemic lupus erythematosus	5.14e-05	0.000476	CcSEcCtD
Erlotinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	5.13e-05	0.000475	CcSEcCtD
Erlotinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	5.1e-05	0.000473	CcSEcCtD
Erlotinib—Skin disorder—Prednisone—systemic lupus erythematosus	5.08e-05	0.00047	CcSEcCtD
Erlotinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.04e-05	0.000467	CcSEcCtD
Erlotinib—Vomiting—Cyclosporine—systemic lupus erythematosus	5.03e-05	0.000466	CcSEcCtD
Erlotinib—Rash—Cyclosporine—systemic lupus erythematosus	4.99e-05	0.000462	CcSEcCtD
Erlotinib—Anorexia—Prednisone—systemic lupus erythematosus	4.99e-05	0.000462	CcSEcCtD
Erlotinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.98e-05	0.000461	CcSEcCtD
Erlotinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	4.97e-05	0.000461	CcSEcCtD
Erlotinib—Headache—Cyclosporine—systemic lupus erythematosus	4.96e-05	0.000459	CcSEcCtD
Erlotinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	4.91e-05	0.000455	CcSEcCtD
Erlotinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	4.91e-05	0.000455	CcSEcCtD
Erlotinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	4.91e-05	0.000454	CcSEcCtD
Erlotinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	4.87e-05	0.000451	CcSEcCtD
Erlotinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	4.86e-05	0.00045	CcSEcCtD
Erlotinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	4.83e-05	0.000448	CcSEcCtD
Erlotinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	4.81e-05	0.000445	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	4.77e-05	0.000441	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—systemic lupus erythematosus	4.76e-05	0.000441	CcSEcCtD
Erlotinib—Asthenia—Triamcinolone—systemic lupus erythematosus	4.75e-05	0.00044	CcSEcCtD
Erlotinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.75e-05	0.00044	CcSEcCtD
Erlotinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.75e-05	0.00044	CcSEcCtD
Erlotinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.75e-05	0.00044	CcSEcCtD
Erlotinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.75e-05	0.00044	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.74e-05	0.000439	CcSEcCtD
Erlotinib—Insomnia—Prednisone—systemic lupus erythematosus	4.73e-05	0.000438	CcSEcCtD
Erlotinib—Nausea—Cyclosporine—systemic lupus erythematosus	4.7e-05	0.000435	CcSEcCtD
Erlotinib—Pruritus—Triamcinolone—systemic lupus erythematosus	4.68e-05	0.000434	CcSEcCtD
Erlotinib—Cough—Methotrexate—systemic lupus erythematosus	4.67e-05	0.000433	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.67e-05	0.000433	CcSEcCtD
Erlotinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	4.65e-05	0.00043	CcSEcCtD
Erlotinib—Dyspepsia—Prednisone—systemic lupus erythematosus	4.6e-05	0.000426	CcSEcCtD
Erlotinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.58e-05	0.000424	CcSEcCtD
Erlotinib—Chest pain—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000422	CcSEcCtD
Erlotinib—Myalgia—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000422	CcSEcCtD
Erlotinib—Arthralgia—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000422	CcSEcCtD
Erlotinib—Decreased appetite—Prednisone—systemic lupus erythematosus	4.55e-05	0.000421	CcSEcCtD
Erlotinib—Rash—Prednisolone—systemic lupus erythematosus	4.54e-05	0.00042	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—systemic lupus erythematosus	4.53e-05	0.00042	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	4.53e-05	0.000419	CcSEcCtD
Erlotinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.52e-05	0.000418	CcSEcCtD
Erlotinib—Fatigue—Prednisone—systemic lupus erythematosus	4.51e-05	0.000418	CcSEcCtD
Erlotinib—Headache—Prednisolone—systemic lupus erythematosus	4.51e-05	0.000418	CcSEcCtD
Erlotinib—Constipation—Prednisone—systemic lupus erythematosus	4.47e-05	0.000414	CcSEcCtD
Erlotinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.47e-05	0.000414	CcSEcCtD
Erlotinib—Rash—Hydrocortisone—systemic lupus erythematosus	4.43e-05	0.00041	CcSEcCtD
Erlotinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.43e-05	0.00041	CcSEcCtD
Erlotinib—Headache—Hydrocortisone—systemic lupus erythematosus	4.4e-05	0.000408	CcSEcCtD
Erlotinib—Dizziness—Triamcinolone—systemic lupus erythematosus	4.38e-05	0.000405	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	4.37e-05	0.000404	CcSEcCtD
Erlotinib—Infection—Methotrexate—systemic lupus erythematosus	4.34e-05	0.000402	CcSEcCtD
Erlotinib—Asthenia—Betamethasone—systemic lupus erythematosus	4.31e-05	0.000399	CcSEcCtD
Erlotinib—Asthenia—Dexamethasone—systemic lupus erythematosus	4.31e-05	0.000399	CcSEcCtD
Erlotinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	4.29e-05	0.000397	CcSEcCtD
Erlotinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.28e-05	0.000396	CcSEcCtD
Erlotinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.28e-05	0.000396	CcSEcCtD
Erlotinib—Nausea—Prednisolone—systemic lupus erythematosus	4.28e-05	0.000396	CcSEcCtD
Erlotinib—Pruritus—Dexamethasone—systemic lupus erythematosus	4.25e-05	0.000393	CcSEcCtD
Erlotinib—Pruritus—Betamethasone—systemic lupus erythematosus	4.25e-05	0.000393	CcSEcCtD
Erlotinib—Skin disorder—Methotrexate—systemic lupus erythematosus	4.25e-05	0.000393	CcSEcCtD
Erlotinib—Vomiting—Triamcinolone—systemic lupus erythematosus	4.21e-05	0.00039	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.2e-05	0.000389	CcSEcCtD
Erlotinib—Nausea—Hydrocortisone—systemic lupus erythematosus	4.18e-05	0.000387	CcSEcCtD
Erlotinib—Rash—Triamcinolone—systemic lupus erythematosus	4.17e-05	0.000386	CcSEcCtD
Erlotinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.17e-05	0.000386	CcSEcCtD
Erlotinib—Anorexia—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000386	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—systemic lupus erythematosus	4.16e-05	0.000386	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.16e-05	0.000385	CcSEcCtD
Erlotinib—Headache—Triamcinolone—systemic lupus erythematosus	4.15e-05	0.000384	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—systemic lupus erythematosus	4.14e-05	0.000383	CcSEcCtD
Erlotinib—Body temperature increased—Prednisone—systemic lupus erythematosus	4.13e-05	0.000383	CcSEcCtD
Erlotinib—Abdominal pain—Prednisone—systemic lupus erythematosus	4.13e-05	0.000383	CcSEcCtD
Erlotinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.11e-05	0.000381	CcSEcCtD
Erlotinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.11e-05	0.000381	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.98e-05	0.000369	CcSEcCtD
Erlotinib—Dizziness—Dexamethasone—systemic lupus erythematosus	3.97e-05	0.000368	CcSEcCtD
Erlotinib—Dizziness—Betamethasone—systemic lupus erythematosus	3.97e-05	0.000368	CcSEcCtD
Erlotinib—Insomnia—Methotrexate—systemic lupus erythematosus	3.95e-05	0.000366	CcSEcCtD
Erlotinib—Nausea—Triamcinolone—systemic lupus erythematosus	3.93e-05	0.000364	CcSEcCtD
Erlotinib—Nausea—Methylprednisolone—systemic lupus erythematosus	3.92e-05	0.000363	CcSEcCtD
Erlotinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.9e-05	0.000361	CcSEcCtD
Erlotinib—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.85e-05	0.000356	CcSEcCtD
Erlotinib—Vomiting—Dexamethasone—systemic lupus erythematosus	3.82e-05	0.000354	CcSEcCtD
Erlotinib—Vomiting—Betamethasone—systemic lupus erythematosus	3.82e-05	0.000354	CcSEcCtD
Erlotinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.8e-05	0.000352	CcSEcCtD
Erlotinib—Rash—Betamethasone—systemic lupus erythematosus	3.79e-05	0.000351	CcSEcCtD
Erlotinib—Rash—Dexamethasone—systemic lupus erythematosus	3.79e-05	0.000351	CcSEcCtD
Erlotinib—Dermatitis—Betamethasone—systemic lupus erythematosus	3.78e-05	0.00035	CcSEcCtD
Erlotinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.78e-05	0.00035	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.77e-05	0.000349	CcSEcCtD
Erlotinib—Fatigue—Methotrexate—systemic lupus erythematosus	3.77e-05	0.000349	CcSEcCtD
Erlotinib—Headache—Dexamethasone—systemic lupus erythematosus	3.76e-05	0.000348	CcSEcCtD
Erlotinib—Headache—Betamethasone—systemic lupus erythematosus	3.76e-05	0.000348	CcSEcCtD
Erlotinib—Asthenia—Prednisone—systemic lupus erythematosus	3.75e-05	0.000348	CcSEcCtD
Erlotinib—Pain—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000346	CcSEcCtD
Erlotinib—Pruritus—Prednisone—systemic lupus erythematosus	3.7e-05	0.000343	CcSEcCtD
Erlotinib—Diarrhoea—Prednisone—systemic lupus erythematosus	3.58e-05	0.000331	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.57e-05	0.000331	CcSEcCtD
Erlotinib—Nausea—Dexamethasone—systemic lupus erythematosus	3.57e-05	0.00033	CcSEcCtD
Erlotinib—Nausea—Betamethasone—systemic lupus erythematosus	3.57e-05	0.00033	CcSEcCtD
Erlotinib—Dizziness—Prednisone—systemic lupus erythematosus	3.46e-05	0.00032	CcSEcCtD
Erlotinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.46e-05	0.00032	CcSEcCtD
Erlotinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.46e-05	0.00032	CcSEcCtD
Erlotinib—Vomiting—Prednisone—systemic lupus erythematosus	3.33e-05	0.000308	CcSEcCtD
Erlotinib—Rash—Prednisone—systemic lupus erythematosus	3.3e-05	0.000305	CcSEcCtD
Erlotinib—Dermatitis—Prednisone—systemic lupus erythematosus	3.29e-05	0.000305	CcSEcCtD
Erlotinib—Headache—Prednisone—systemic lupus erythematosus	3.28e-05	0.000303	CcSEcCtD
Erlotinib—Asthenia—Methotrexate—systemic lupus erythematosus	3.14e-05	0.00029	CcSEcCtD
Erlotinib—Nausea—Prednisone—systemic lupus erythematosus	3.11e-05	0.000288	CcSEcCtD
Erlotinib—Pruritus—Methotrexate—systemic lupus erythematosus	3.09e-05	0.000286	CcSEcCtD
Erlotinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.99e-05	0.000277	CcSEcCtD
Erlotinib—Dizziness—Methotrexate—systemic lupus erythematosus	2.89e-05	0.000268	CcSEcCtD
Erlotinib—Vomiting—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000257	CcSEcCtD
Erlotinib—Rash—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000255	CcSEcCtD
Erlotinib—Dermatitis—Methotrexate—systemic lupus erythematosus	2.75e-05	0.000255	CcSEcCtD
Erlotinib—Headache—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000254	CcSEcCtD
Erlotinib—Nausea—Methotrexate—systemic lupus erythematosus	2.6e-05	0.00024	CcSEcCtD
Erlotinib—ABL1—Developmental Biology—EP300—systemic lupus erythematosus	6.72e-06	0.000102	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—C3—systemic lupus erythematosus	6.71e-06	0.000102	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LYN—systemic lupus erythematosus	6.68e-06	0.000101	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DQB1—systemic lupus erythematosus	6.67e-06	0.000101	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—JAK1—systemic lupus erythematosus	6.61e-06	0.0001	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	6.6e-06	0.0001	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.6e-06	0.0001	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—EP300—systemic lupus erythematosus	6.6e-06	0.0001	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.58e-06	9.99e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2RA—systemic lupus erythematosus	6.57e-06	9.98e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.55e-06	9.95e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—C3—systemic lupus erythematosus	6.52e-06	9.89e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	6.52e-06	9.89e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL2—systemic lupus erythematosus	6.45e-06	9.8e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCL2—systemic lupus erythematosus	6.44e-06	9.78e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—VEGFA—systemic lupus erythematosus	6.37e-06	9.66e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.33e-06	9.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL18—systemic lupus erythematosus	6.33e-06	9.6e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD40LG—systemic lupus erythematosus	6.3e-06	9.57e-05	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.26e-06	9.5e-05	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—VEGFA—systemic lupus erythematosus	6.25e-06	9.48e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CDKN1A—systemic lupus erythematosus	6.24e-06	9.47e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.24e-06	9.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	6.24e-06	9.46e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD8A—systemic lupus erythematosus	6.23e-06	9.46e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.2e-06	9.41e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CRP—systemic lupus erythematosus	6.2e-06	9.41e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	6.17e-06	9.37e-05	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—IL6—systemic lupus erythematosus	6.17e-06	9.37e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.15e-06	9.33e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD4—systemic lupus erythematosus	6.15e-06	9.33e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP9—systemic lupus erythematosus	6.11e-06	9.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—C3—systemic lupus erythematosus	6.1e-06	9.25e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.09e-06	9.24e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—RXRA—systemic lupus erythematosus	6.09e-06	9.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP9—systemic lupus erythematosus	6.06e-06	9.2e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—JAK1—systemic lupus erythematosus	6.02e-06	9.13e-05	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	5.97e-06	9.05e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.96e-06	9.05e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TLR4—systemic lupus erythematosus	5.95e-06	9.02e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DRB1—systemic lupus erythematosus	5.94e-06	9.01e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—EP300—systemic lupus erythematosus	5.94e-06	9.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD4—systemic lupus erythematosus	5.9e-06	8.96e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—F2—systemic lupus erythematosus	5.89e-06	8.94e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	5.87e-06	8.92e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TYK2—systemic lupus erythematosus	5.85e-06	8.88e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TGFB1—systemic lupus erythematosus	5.84e-06	8.87e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—IL6—systemic lupus erythematosus	5.83e-06	8.84e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—EP300—systemic lupus erythematosus	5.79e-06	8.79e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CDKN1B—systemic lupus erythematosus	5.78e-06	8.77e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—EP300—systemic lupus erythematosus	5.74e-06	8.72e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NOS3—systemic lupus erythematosus	5.74e-06	8.71e-05	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TGFB1—systemic lupus erythematosus	5.73e-06	8.7e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	5.72e-06	8.68e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NAT2—systemic lupus erythematosus	5.68e-06	8.63e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—RXRA—systemic lupus erythematosus	5.68e-06	8.62e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CD80—systemic lupus erythematosus	5.65e-06	8.57e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2RA—systemic lupus erythematosus	5.62e-06	8.53e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—C3—systemic lupus erythematosus	5.57e-06	8.45e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—JAK1—systemic lupus erythematosus	5.55e-06	8.43e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	5.55e-06	8.42e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD80—systemic lupus erythematosus	5.49e-06	8.33e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.49e-06	8.33e-05	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	5.47e-06	8.31e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—systemic lupus erythematosus	5.46e-06	8.28e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—VEGFA—systemic lupus erythematosus	5.44e-06	8.26e-05	CbGpPWpGaD
Erlotinib—MKNK1—Disease—IL6—systemic lupus erythematosus	5.42e-06	8.22e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.39e-06	8.18e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.38e-06	8.16e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—F2—systemic lupus erythematosus	5.37e-06	8.15e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—F2—systemic lupus erythematosus	5.35e-06	8.12e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CDKN1A—systemic lupus erythematosus	5.33e-06	8.09e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—systemic lupus erythematosus	5.3e-06	8.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—JUNB—systemic lupus erythematosus	5.28e-06	8.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—IL6—systemic lupus erythematosus	5.27e-06	8e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.26e-06	7.99e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CCR5—systemic lupus erythematosus	5.26e-06	7.99e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL2—systemic lupus erythematosus	5.25e-06	7.97e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	5.16e-06	7.84e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	5.12e-06	7.77e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR4—systemic lupus erythematosus	5.08e-06	7.71e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DRB1—systemic lupus erythematosus	5.07e-06	7.7e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—EP300—systemic lupus erythematosus	5.07e-06	7.7e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.03e-06	7.64e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.03e-06	7.64e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.01e-06	7.61e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5e-06	7.6e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TGFB1—systemic lupus erythematosus	4.99e-06	7.58e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	4.98e-06	7.56e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.97e-06	7.55e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.96e-06	7.52e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL2—systemic lupus erythematosus	4.87e-06	7.39e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PRL—systemic lupus erythematosus	4.86e-06	7.38e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL6—systemic lupus erythematosus	4.84e-06	7.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.77e-06	7.24e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TYK2—systemic lupus erythematosus	4.77e-06	7.24e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	4.69e-06	7.12e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD80—systemic lupus erythematosus	4.69e-06	7.12e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NOS3—systemic lupus erythematosus	4.68e-06	7.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—systemic lupus erythematosus	4.66e-06	7.08e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TYK2—systemic lupus erythematosus	4.63e-06	7.03e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—systemic lupus erythematosus	4.61e-06	6.99e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.59e-06	6.97e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.54e-06	6.9e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.52e-06	6.86e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.46e-06	6.76e-05	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—systemic lupus erythematosus	4.43e-06	6.72e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—systemic lupus erythematosus	4.4e-06	6.68e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—EP300—systemic lupus erythematosus	4.37e-06	6.63e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—systemic lupus erythematosus	4.34e-06	6.58e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.33e-06	6.57e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD80—systemic lupus erythematosus	4.33e-06	6.57e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS3—systemic lupus erythematosus	4.27e-06	6.48e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—systemic lupus erythematosus	4.19e-06	6.36e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.14e-06	6.28e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.09e-06	6.2e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.05e-06	6.15e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	3.98e-06	6.03e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2—systemic lupus erythematosus	3.97e-06	6.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TYK2—systemic lupus erythematosus	3.96e-06	6.01e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CDKN1B—systemic lupus erythematosus	3.94e-06	5.98e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.9e-06	5.92e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—systemic lupus erythematosus	3.89e-06	5.9e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—JAK1—systemic lupus erythematosus	3.89e-06	5.9e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2—systemic lupus erythematosus	3.85e-06	5.85e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	3.84e-06	5.83e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.8e-06	5.76e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—systemic lupus erythematosus	3.79e-06	5.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—systemic lupus erythematosus	3.76e-06	5.71e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—systemic lupus erythematosus	3.76e-06	5.7e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.74e-06	5.68e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—systemic lupus erythematosus	3.71e-06	5.63e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	3.7e-06	5.62e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR5—systemic lupus erythematosus	3.69e-06	5.59e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TYK2—systemic lupus erythematosus	3.65e-06	5.55e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CDKN1A—systemic lupus erythematosus	3.63e-06	5.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.63e-06	5.51e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2—systemic lupus erythematosus	3.62e-06	5.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2—systemic lupus erythematosus	3.6e-06	5.47e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—C3—systemic lupus erythematosus	3.6e-06	5.47e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—systemic lupus erythematosus	3.59e-06	5.44e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARG—systemic lupus erythematosus	3.58e-06	5.44e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—systemic lupus erythematosus	3.58e-06	5.43e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.57e-06	5.42e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—EP300—systemic lupus erythematosus	3.56e-06	5.4e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.55e-06	5.39e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	3.5e-06	5.31e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—EP300—systemic lupus erythematosus	3.46e-06	5.25e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	3.46e-06	5.24e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.38e-06	5.14e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.37e-06	5.12e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CDKN1B—systemic lupus erythematosus	3.37e-06	5.11e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—systemic lupus erythematosus	3.32e-06	5.04e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	3.31e-06	5.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—systemic lupus erythematosus	3.3e-06	5.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2—systemic lupus erythematosus	3.29e-06	5e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—systemic lupus erythematosus	3.28e-06	4.98e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	3.26e-06	4.95e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—EP300—systemic lupus erythematosus	3.25e-06	4.93e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.24e-06	4.92e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—systemic lupus erythematosus	3.22e-06	4.89e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	3.2e-06	4.86e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—RXRA—systemic lupus erythematosus	3.19e-06	4.84e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—F2—systemic lupus erythematosus	3.16e-06	4.8e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.16e-06	4.8e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CDKN1B—systemic lupus erythematosus	3.11e-06	4.72e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CDKN1A—systemic lupus erythematosus	3.11e-06	4.71e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.1e-06	4.7e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—systemic lupus erythematosus	3.08e-06	4.68e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	3.07e-06	4.67e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.07e-06	4.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CD80—systemic lupus erythematosus	3.03e-06	4.6e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	3.02e-06	4.59e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.97e-06	4.51e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.96e-06	4.49e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—EP300—systemic lupus erythematosus	2.96e-06	4.49e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—systemic lupus erythematosus	2.93e-06	4.45e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CDKN1A—systemic lupus erythematosus	2.87e-06	4.35e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—systemic lupus erythematosus	2.86e-06	4.34e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.84e-06	4.31e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	2.82e-06	4.28e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—systemic lupus erythematosus	2.82e-06	4.28e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—systemic lupus erythematosus	2.82e-06	4.28e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	2.8e-06	4.26e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	2.79e-06	4.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—EP300—systemic lupus erythematosus	2.73e-06	4.14e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.63e-06	3.99e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	2.56e-06	3.89e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TYK2—systemic lupus erythematosus	2.56e-06	3.88e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	2.51e-06	3.82e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—systemic lupus erythematosus	2.51e-06	3.81e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.49e-06	3.77e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—systemic lupus erythematosus	2.37e-06	3.6e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—EP300—systemic lupus erythematosus	2.34e-06	3.56e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	2.34e-06	3.55e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—systemic lupus erythematosus	2.33e-06	3.54e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—systemic lupus erythematosus	2.27e-06	3.44e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	2.23e-06	3.38e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	2.21e-06	3.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.18e-06	3.3e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—EP300—systemic lupus erythematosus	2.13e-06	3.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2—systemic lupus erythematosus	2.13e-06	3.23e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—systemic lupus erythematosus	2.12e-06	3.22e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	2.1e-06	3.19e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.07e-06	3.14e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.02e-06	3.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—systemic lupus erythematosus	2.02e-06	3.06e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—systemic lupus erythematosus	2.01e-06	3.05e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	2.01e-06	3.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.01e-06	3.05e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	1.98e-06	3.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—systemic lupus erythematosus	1.94e-06	2.94e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EP300—systemic lupus erythematosus	1.91e-06	2.9e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	1.9e-06	2.88e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	1.84e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.82e-06	2.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.81e-06	2.75e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—systemic lupus erythematosus	1.79e-06	2.71e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.76e-06	2.68e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.74e-06	2.64e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	1.74e-06	2.64e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.73e-06	2.63e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.72e-06	2.61e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.66e-06	2.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.66e-06	2.52e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.59e-06	2.42e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.59e-06	2.41e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.58e-06	2.4e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	1.53e-06	2.32e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.52e-06	2.3e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.49e-06	2.27e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	1.44e-06	2.19e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.43e-06	2.17e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.41e-06	2.14e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.39e-06	2.1e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.32e-06	2.01e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—EP300—systemic lupus erythematosus	1.32e-06	2e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.31e-06	1.98e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	1.27e-06	1.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—systemic lupus erythematosus	1.25e-06	1.9e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	1.21e-06	1.84e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.15e-06	1.75e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.11e-06	1.68e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.09e-06	1.65e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.09e-06	1.65e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	9.77e-07	1.48e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	9.34e-07	1.42e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	9.21e-07	1.4e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	8.54e-07	1.3e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.11e-07	1.08e-05	CbGpPWpGaD
